132 related articles for article (PubMed ID: 6692425)
21. [Antitumor antibiotics: unresolved problems and the prospects for further search].
Navashin SM; Egorov LV
Vestn Akad Med Nauk SSSR; 1982; (12):80-5. PubMed ID: 6760588
[No Abstract] [Full Text] [Related]
22. Intravesical bacillus Calmette-Guérin combined with electromotive mitomycin for high-risk superficial bladder cancer.
Bochner BH
Nat Clin Pract Oncol; 2006 Sep; 3(9):474-5. PubMed ID: 16955082
[No Abstract] [Full Text] [Related]
23. [Antitumor activity of beromycin].
Shorin VA; Averbukh LA; Bazhanov VS; Rossolimo OK; Lepeshkina GW
Antibiotiki; 1972 May; 17(5):432-6. PubMed ID: 5067713
[No Abstract] [Full Text] [Related]
24. Attempts to enhance antitumor activity of iyomycin B1.
Hata T; Umesawa I; Kanda N
Antimicrob Agents Chemother (Bethesda); 1966; 6():540-2. PubMed ID: 5985285
[No Abstract] [Full Text] [Related]
25. [Use of an express method in studying the cytotoxic action of antitumor antibiotics].
Makukho LV; Volkolupova OP
Antibiotiki; 1981 Mar; 26(3):130-2. PubMed ID: 7235656
[TBL] [Abstract][Full Text] [Related]
26. Recent advances in antitumor antibiotics.
Umezawa H
Antibiot Chemother (1971); 1978; 23():76-87. PubMed ID: 77145
[TBL] [Abstract][Full Text] [Related]
27. Experimental antitumor agents from plants, 1974-76.
Cordell GA; Farnsworth NR
Lloydia; 1977; 40(1):1-44. PubMed ID: 327182
[TBL] [Abstract][Full Text] [Related]
28. Influence of the structure of new anthracycline antibiotics on their biological properties.
Wasowska M; Oszczapowicz I; Wietrzyk J; Opolski A; Madej J; Dzimira S; Oszczapowicz J
Anticancer Res; 2005; 25(3B):2043-8. PubMed ID: 16158943
[TBL] [Abstract][Full Text] [Related]
29. Experimental antitumor activity and toxicity of a new chemotherapeutic agent, BBM 928A.
Rose WC; Schurig JE; Huftalen JB; Bradner WT
Cancer Res; 1983 Apr; 43(4):1504-10. PubMed ID: 6831399
[No Abstract] [Full Text] [Related]
30. [Studies on treatment with antitumor agents--short-term observations on the effects in vitro].
Katsuta K; Hisatsune K; Kajiyama M; Miyahara H; Atsumi T
Iryo; 1967 Oct; 21(10):1183-92. PubMed ID: 5590371
[No Abstract] [Full Text] [Related]
31. Marker tumour responses to the sequential combination of intravesical therapy with mitomycin-C and BCG-RIVM in multiple superficial bladder tumours. Report from the European Organisation for Research and Treatment on Cancer-Genitourinary Group (EORTC 30897).
Van der Meijden AP; Hall RR; Macaluso MP; Pawinsky A; Sylvester R; Van Glabbeke M
Eur Urol; 1996; 29(2):199-203. PubMed ID: 8647147
[TBL] [Abstract][Full Text] [Related]
32. [High molecular weight antineoplastic antibiotics of a polypeptide or protein nature formed by Actinomycetes].
Kuimova TF
Antibiotiki; 1966 Jul; 11(7):651-6. PubMed ID: 5997589
[No Abstract] [Full Text] [Related]
33. [Antitumor activity and toxicity of combined doxorubicin and disodium salt of methylene-1,1-diphosphonic acid].
Stukov AN; Mironiuk TN; Kon'kov SA; Krylova IM; Reztsova VV; Filov VA; Ivin BA
Vopr Onkol; 1998; 44(1):100-2. PubMed ID: 9578741
[TBL] [Abstract][Full Text] [Related]
34. Maitake extracts and their therapeutic potential.
Mayell M
Altern Med Rev; 2001 Feb; 6(1):48-60. PubMed ID: 11207456
[TBL] [Abstract][Full Text] [Related]
35. Peptides and antitumor activity. Development and investigation of some peptides with antitumor activity.
Teplán I
Acta Biol Hung; 2000; 51(1):1-29. PubMed ID: 10866357
[TBL] [Abstract][Full Text] [Related]
36. Effect of structural modifications of anthracyclines on the ability to overcome drug resistance of cancer cells.
Wasowska M; Wietrzyk J; Opolski A; Oszczapowicz J; Oszczapowicz I
Anticancer Res; 2006; 26(3A):2009-12. PubMed ID: 16827137
[TBL] [Abstract][Full Text] [Related]
37. The preclinical new drug research program of the National Cancer Institute.
Driscoll JS
Cancer Treat Rep; 1984 Jan; 68(1):63-76. PubMed ID: 6692438
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and antitumor activity of duocarmycin derivatives: A-ring pyrrole compounds bearing cinnamoyl groups.
Nagamura S; Asai A; Amishiro N; Kobayashi E; Gomi K; Saito H
J Med Chem; 1997 Mar; 40(6):972-9. PubMed ID: 9083487
[TBL] [Abstract][Full Text] [Related]
39. Studies on low-molecular-weight immunomodifiers produced by microorganisms: results of ten years' effort.
Umezawa H
Rev Infect Dis; 1984; 6(3):412-20. PubMed ID: 6234644
[TBL] [Abstract][Full Text] [Related]
40. Biochemical and pharmacological activity of novel 8-fluoroanthracyclines: influence of stereochemistry and conformation.
Animati F; Arcamone F; Bigioni M; Capranico G; Caserini C; De Cesare M; Lombardi P; Pratesi G; Salvatore C; Supino R; Zunino F
Mol Pharmacol; 1996 Sep; 50(3):603-9. PubMed ID: 8794900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
